Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

The DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m). It comes two months after the company filed for bankruptcy protection in the US.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly handed over the samples to completely different owners.

Me has found a buyer in biotech company Regeneron Pharmaceuticals. If you want your data removed, here are your options.

Regeneron Pharmaceuticals plans to purchase 23andMe just two months after the genetics company filed for bankruptcy.

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do not face